Registered Tanzania · TMDA

Amprolium 20%

Amprolium Hydrochloride 20 %w/w

TAN 00,4131 P01X LAP Powder 20 INN generic

What it does

Amprolium is a medication used to treat certain infections in animals caused by parasites.

Commonly used for: coccidiosis, intestinal parasite infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TAN 00,4131 P01X LAP
Registration date
2023-06-26
Expiry date
2028-06-25
Status
Registered/Compliant
Active ingredient
Amprolium Hydrochloride 20 %w/w
Dosage form
Powder
Strength
20
Pack size
-
Therapeutic class
-
RxNorm RxCUI
1006654
Manufacturer / MAH
Biove Laboratories
Applicant / LTR
LAPROVET
Country of origin
FRANCE
Manufacturer location
3 Rue de Lorraine, 62510 Arques, France

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-03-11 23:42:31 · updated 2026-09-17 03:00:43

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About this medicine

Amprolium is a medication used to treat certain infections in animals caused by parasites.

What it treats

  • coccidiosis
  • intestinal parasite infections

How it works

Amprolium works by interfering with the growth and reproduction of parasites in the intestines.

Who it's for

This medication is typically used in animals, particularly in livestock and pets, to manage parasitic infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: amprolium

BNF-referenced

Amprolium is an antiprotozoal agent primarily used in veterinary medicine to treat coccidiosis in livestock and poultry. It is effective against various Eimeria species, which are responsible for coccidial infections that can lead to significant health issues and economic losses in animal farming. Its mechanism of action involves interference with the metabolism of the parasites, specifically targeting thiamine (vitamin B1) utilization.

Indications

  • Coccidiosis in poultry
  • Coccidiosis in livestock
  • Prevention of coccidial infections in animals

Dosage

Children: Refer to veterinary guidelines for specific dosing for younger animals, as it may vary according to weight and age.

Adults: Refer to veterinary guidelines for specific dosing based on the type of animal and severity of infection.

Mechanism of action

Amprolium acts as a thiamine antagonist, inhibiting the uptake of thiamine in the protozoa. This leads to depletion of thiamine within the parasites, which is essential for their energy metabolism and growth. The lack of thiamine disrupts several metabolic pathways, ultimately resulting in the death of the parasitic organisms.

Pharmacodynamics

Amprolium exhibits selective toxicity towards protozoa by exploiting the differences in thiamine metabolism between the host and the parasite. The drug's action is primarily coccidiostatic, preventing the development and reproduction of Eimeria species. The effectiveness of amprolium is influenced by factors such as the specific strain of Eimeria, the dosage administered, and the duration of treatment.

Pharmacokinetics

Amprolium is well absorbed after oral administration, with peak plasma concentrations occurring within a few hours. It is primarily metabolized in the liver, and its metabolites are excreted mainly through the urine. The drug has a relatively short half-life, necessitating multiple doses for effective treatment. The pharmacokinetic profile may vary between species, and veterinary guidelines should be followed for specific dosing regimens.

Adverse effects

  • Anorexia
  • Weight loss
  • Neurological signs including ataxia
  • Thiamine deficiency symptoms

Precautions

  • Use with caution in animals with pre-existing neurological conditions
  • Monitor for signs of thiamine deficiency

Pregnancy

There are no adequate and well-controlled studies in pregnant animals. Use with caution.

Breast-feeding

Not established. Caution is advised.

Storage

Store in a cool, dry place, away from light.

Formulations

  • Oral powder
  • Oral solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: amprolium

PubChem CID 73341

Molecular formula: C14H19ClN4

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.